These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38033489)

  • 1. Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy.
    Matsui T; Toda Y; Sato H; Itagaki R; Konishi K; Moshnikova A; Andreev OA; Hosogi S; Reshetnyak YK; Ashihara E
    Front Oncol; 2023; 13():1258442. PubMed ID: 38033489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes.
    Adochite RC; Moshnikova A; Golijanin J; Andreev OA; Katenka NV; Reshetnyak YK
    Mol Imaging Biol; 2016 Oct; 18(5):686-96. PubMed ID: 27074841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-responsive pHLIP (pH low insertion peptide) nanoclusters of superparamagnetic iron oxide nanoparticles as a tumor-selective MRI contrast agent.
    Wei Y; Liao R; Mahmood AA; Xu H; Zhou Q
    Acta Biomater; 2017 Jun; 55():194-203. PubMed ID: 28363789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.
    Reshetnyak YK; Yao L; Zheng S; Kuznetsov S; Engelman DM; Andreev OA
    Mol Imaging Biol; 2011 Dec; 13(6):1146-56. PubMed ID: 21181501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
    Zhang M; Xi Y; Chen H; Hai W; Li B
    Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting breast tumors with pH (low) insertion peptides.
    Adochite RC; Moshnikova A; Carlin SD; Guerrieri RA; Andreev OA; Lewis JS; Reshetnyak YK
    Mol Pharm; 2014 Aug; 11(8):2896-905. PubMed ID: 25004202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
    Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
    Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
    Wu F; Chen Y; Li D; Wang Z; Yu M
    Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
    Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor treatment by pHLIP-targeted antigen delivery.
    DuPont M; Visca H; Moshnikova A; Engelman DM; Reshetnyak YK; Andreev OA
    Front Bioeng Biotechnol; 2022; 10():1082290. PubMed ID: 36686229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
    Svoronos AA; Engelman DM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
    Yu M; Chen Y; Wang Z; Ding X
    Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery.
    Rinaldi F; Hanieh PN; Del Favero E; Rondelli V; Brocca P; Pereira MC; Andreev OA; Reshetnyak YK; Marianecci C; Carafa M
    Nanoscale Res Lett; 2018 Dec; 13(1):391. PubMed ID: 30515583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation.
    Kaplan AR; Pham H; Liu Y; Oyaghire S; Bahal R; Engelman DM; Glazer PM
    Mol Cancer Res; 2020 Jun; 18(6):873-882. PubMed ID: 32098827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.
    Chen Y; Su Y; Pang X; Song X; Zhao W; Yu M
    Front Oncol; 2022; 12():869260. PubMed ID: 35530359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Acidic Microenvironment Targeted Drug Delivery Based on pHLIP-Modified Mesoporous Organosilica Nanoparticles.
    Zhang Y; Dang M; Tian Y; Zhu Y; Liu W; Tian W; Su Y; Ni Q; Xu C; Lu N; Tao J; Li Y; Zhao S; Zhao Y; Yang Z; Sun L; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30543-30552. PubMed ID: 28809111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
    Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
    Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.